Kolexia
Nguyen Lee
Cardiologie
Cmc Ambroise Pare Hartmann Site 25
Neuilly-sur-Seine, France
166 Activités
21 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Cardiopathies Défaillance cardiaque Cardiotoxicité Cardiomyopathies Insuffisance respiratoire Infarctus du myocarde Complications postopératoires Apnée

Industries

Bayer
4 collaboration(s)
Dernière en 2023
WorldOne
2 collaboration(s)
Dernière en 2020
Sanofi
2 collaboration(s)
Dernière en 2022
Organon BioSciences
1 collaboration(s)
Dernière en 2021

Dernières activités

RIPOSTE: Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry
Essai Clinique (Hôpital Ambroise Paré)   09 janvier 2024
VR-INVENT: Effect of Virtual Reality On IN-Vitro fEcuNdation ouTcomes: a Randomized Controlled Trial (VR-INVENT)
Essai Clinique (Hôpital Ambroise Paré)   09 janvier 2024
Impact of sex differences on cardiac injury in critically ill patients with COVID-19.
Respiratory research   20 novembre 2023
JOCARDITE: JOint Use of Database to Identify Risk Factors of CARDio-vascular Adverse Reactions Induced by Immune Checkpoint InhibiTors: VigiBase, Entrepot de Données de Santé (EDS), Système National Des Données de Santé (SNDS) Databases and a Retrospective International Multicenter Registry of ICI-associated Myocarditis
Essai Clinique (Hôpital Pitie Salpetriere)   14 septembre 2023
Prognosis of Right Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy.
Journal of the American Heart Association   10 août 2023
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.
Cancer discovery   05 mai 2023
Effectiveness of Simulation-Based Training on Transesophageal Echocardiography Learning: The SIMULATOR Randomized Clinical Trial.
JAMA cardiology   19 avril 2023
CARTABLE: Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
Essai Clinique (Hôpital Pitie Salpetriere)   12 avril 2023
EROCA: Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)
Essai Clinique (Hôpital Pitie Salpetriere)   12 avril 2023
Takotsubo cardiomyopathy after cardiac surgery: A case-series and systematic review of literature.
Frontiers in cardiovascular medicine   10 janvier 2023